The Pregabalin Capsules, cataloged under National Stock Number 6505-01-713-4547, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sciegen Pharmaceuticals Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-713-4547 |
| Primary Part Number | NDC50228-0351-90 |
| Item Name | Pregabalin Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sciegen Pharmaceuticals Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 90.0 |
| Active Medicament Medicinal Strength | 50.0 MILLIGRAMS PREGABALIN CAPSULES ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC50228-0351-90 PRIMARY | Sciegen Pharmaceuticals Inc (USA) |
| NDC62135-0444-90 | Chartwell Rx Llc (USA) |
| NDC59762-1344-01 | Greenstone Llc (USA) |
| NDC76282-0569-90 PRIMARY | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
| Reference | Meaning |
|---|---|
| 1654637 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM239169 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-713-4547 is a Pregabalin Capsules, manufactured by Sciegen Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-713-4547 has 4 manufacturer part numbers on file: NDC50228-0351-90 (Sciegen Pharmaceuticals Inc), NDC62135-0444-90 (Chartwell Rx Llc), NDC59762-1344-01 (Greenstone Llc), NDC76282-0569-90 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals).
Key specifications for NDC50228-0351-90: Administration: ORAL; Primary Container Type: BOTTLE; Special Features: PREGABALIN CAPSULES CV 50 MG, BOTTLE OF 90CT.STORE AT ROOM TEMPERATURE BETWEEN 20 C TO 25 C (68 F TO 77 F); (SEE USP CONTROLLED ROOM TEMPERATURE. SCHEDULED V DRUG.; Capsule Primary Container Content Quantity: 90.0. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.